Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Direct Selective Laser Trabeculoplasty (DSLT) In Open Angle Glaucoma (POAG): A Randomized Controlled Trial
Brief Summary: Glaucoma is an eye disease that results in damage to the optic nerve that progresses over time. One of the main risk factors in glaucoma is an increase in intraocular pressure, caused by a build-up of fluid in the eye. Glaucoma can result in blindness if left untreated and as such it is extremely important to diagnose and treat the condition.

Selective Laser Trabeculoplasty (SLT) is a laser treatment that facilitates the outflow of fluid from inside the eye. This has the potential of reducing the intraocular pressure within the eye (the main way in which this disease is treated since there is no cure) and may assist in helping to control the progression of this disease.

SLT (standard treatment) is a technique routinely carried out by glaucoma specialists. It is conducted using a special type of lens (goniolens) that gently sits on the front surface of the eye. The procedure takes approximately 5 minutes in duration.

This new treatment, Direct Selective Laser Trabeculoplasty (DSLT) is performed directly, without there being any need to use a goniolens which sits on the eye, and it is a shorter and simpler technique to conduct when compared to the standard SLT technique.

The purpose of this study is to assess the hypothesis that the treatment by new automated device for DSLT is not worse in comparison with the standard SLT and determine that it is effective in reducing intraocular pressure.


Options:
A: Arm Label: Selective laser trabeculoplasty; Type: EXPERIMENTAL; Interventions: Device: Selective laser trabeculoplasty | Arm Label: Travoprost; Type: ACTIVE_COMPARATOR; Interventions: Drug: Travoprost | Intervention Type: DEVICE; Name: Selective laser trabeculoplasty; Assigned to Arm(s): Selective laser trabeculoplasty | Intervention Type: DRUG; Name: Travoprost; Assigned to Arm(s): Travoprost
B: Intervention Type: DRUG; Name: prednisolone acetate 1%; Assigned to Arm(s): N/A
C: Arm Label: Argon laser trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Argon laser trabeculoplasty, Procedure: Selective laser trabeculoplasty | Arm Label: selective laser trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Argon laser trabeculoplasty, Procedure: Selective laser trabeculoplasty | Intervention Type: PROCEDURE; Name: Argon laser trabeculoplasty; Assigned to Arm(s): Argon laser trabeculoplasty, selective laser trabeculoplasty | Intervention Type: PROCEDURE; Name: Selective laser trabeculoplasty; Assigned to Arm(s): Argon laser trabeculoplasty, selective laser trabeculoplasty
D: Arm Label: Direct Selective Trabeculoplasty; Type: EXPERIMENTAL; Interventions: Device: Direct Selective Trabeculoplasty | Arm Label: Selective Trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Device: Selective Trabeculoplasty | Intervention Type: DEVICE; Name: Direct Selective Trabeculoplasty; Assigned to Arm(s): Direct Selective Trabeculoplasty | Intervention Type: DEVICE; Name: Selective Trabeculoplasty; Assigned to Arm(s): Selective Trabeculoplasty

Answer: D